{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:42:09Z","timestamp":1770518529577,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.vaccine.2019.02.083","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T21:22:08Z","timestamp":1552771328000},"page":"2268-2277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines"],"prefix":"10.1016","volume":"37","author":[{"given":"Beatriz P.","family":"Quiambao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ambas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherylle","family":"Diego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Bosch Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Korejwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Houillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.083_b0005","doi-asserted-by":"crossref","unstructured":"World Health Organization (WHO). Rabies vaccines: WHO position paper \u2013 April 2018. Weekly epidemiological record. 2018;93:201\u201320. https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.082.","DOI":"10.1016\/j.vaccine.2010.08.082"},{"key":"10.1016\/j.vaccine.2019.02.083_b0010","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.02.083_b0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.actatropica.2015.12.007","article-title":"Difficulties in estimating the human burden of canine rabies","volume":"165","author":"Taylor","year":"2017","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2019.02.083_b0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/ip.2007.016220","article-title":"Dog bites: still a problem?","volume":"14","author":"Gilchrist","year":"2008","journal-title":"Inj Prev"},{"key":"10.1016\/j.vaccine.2019.02.083_b0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/jech-2017-209330","article-title":"How many people have been bitten by dogs? A cross-sectional survey of prevalence, incidence and factors associated with dog bites in a UK community","volume":"72","author":"Westgarth","year":"2018","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.vaccine.2019.02.083_b0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.actatropica.2016.04.015","article-title":"A prospective study on the incidence of dog bites and management in a rural Cambodian, rabies-endemic setting","volume":"160","author":"Ponsich","year":"2016","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2019.02.083_b0035","unstructured":"World Health Organization (WHO). Human and dog rabies prevention and control. Report of the WHO\/Bill & Melinda Gates Foundation Consultation, Annecy, France, 7\u20139 October 2009, http:\/\/whqlibdoc.who.int\/hq\/2010\/WHO_HTM_NTD_NZD_2010.1_eng.pdf; [accessed 11 June 2018]."},{"key":"10.1016\/j.vaccine.2019.02.083_b0040","doi-asserted-by":"crossref","unstructured":"World Health Organization (WHO). Rabies vaccines: WHO position paper\u2013recommendations. Vaccine. 2010;28:7140\u20132. https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.082.","DOI":"10.1016\/j.vaccine.2010.08.082"},{"key":"10.1016\/j.vaccine.2019.02.083_b0045","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/656585","article-title":"A 4-site, single-visit intradermal postexposure prophylaxis regimen for previously vaccinated patients: experiences with >5000 patients","volume":"51","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.083_b0050","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4161\/hv.20471","article-title":"Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India","volume":"8","author":"Sudarshan","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.02.083_b0055","unstructured":"Novartis Vaccines and Diagnostics. Clinical Trials Results Database V49_30, https:\/\/www.novctrd.com\/CtrdWeb\/terms.nov; 2016 [accessed 11 June 2018]."},{"key":"10.1016\/j.vaccine.2019.02.083_b0060","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/21645515.2015.1048938","article-title":"Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4\u20134-4-0-0) in animal bite cases","volume":"11","author":"Narayana","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.02.083_b0065","unstructured":"WHO\/Department of control of neglected tropical diseases. Laboratory techniques in rabies: 5th ed., http:\/\/www.who.int\/rabies\/resources\/who-cds-ntd-nzd-2018.03\/en\/; 2018 [accessed 06 December 2018]."},{"key":"10.1016\/j.vaccine.2019.02.083_b0070","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"3","author":"Reed","year":"1938","journal-title":"Am J Hyg."},{"key":"10.1016\/j.vaccine.2019.02.083_b0075","unstructured":"Luo P, Timiryasova T, Singer A, Zheng L, Zedar R, Garg S, et al. Evaluation of the Rapid Fluorescent Focus Inhibition Test to Support Rabies Vaccine Development [Abstract, Poster Presentation]. Rabies in the Americas (RITA) Conference, October 23th to October 28th 2016. Bel\u00e9m, Par\u00e1, Brazil."},{"key":"10.1016\/j.vaccine.2019.02.083_b0080","unstructured":"Timiryasova T, Luo P, Zheng L, Singer A, Zedar R, Garg S, et al. Validation of the Rapid Fluorescent Focus Inhibition Test To Measure Rabies Virus Neutralizing Antibodies [Abstract, Oral Presentation, Poster Presentation]. Rabies in the Americas (RITA) Conference, October 23th to October 28th 2016. Bel\u00e9m, Par\u00e1, Brazil."},{"key":"10.1016\/j.vaccine.2019.02.083_b0085","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of Analytical Procedures: Text and Methodology. Q2 (R1), 2005. 1, http:\/\/www.ich.org\/products\/guidelines\/quality\/quality-single\/article\/validation-of-analytical-procedures-text-and-methodology.html; [accessed 16 July 2018]."},{"key":"10.1016\/j.vaccine.2019.02.083_b0090","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2019.02.083_b0095","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2019.02.083_b0100","doi-asserted-by":"crossref","first-page":"e0006340","DOI":"10.1371\/journal.pntd.0006340","article-title":"Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: results from a phase III clinical trial in children, adolescents and adults","volume":"12","author":"Kerdpanich","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.02.083_b0105","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.02.083_b0110","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0264-410X(94)90308-5","article-title":"A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis","volume":"12","author":"Suntharasamai","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.083_b0115","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/344954","article-title":"Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin","volume":"35","author":"Khawplod","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.083_b0120","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/21645515.2016.1255834","article-title":"Injecting rabies immunoglobulin (RIG) into wounds only: a significant saving of lives and costly RIG","volume":"13","author":"Bharti","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.02.083_b0125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/21645515.2015.1085142","article-title":"Local infiltration of rabies immunoglobulins without systemic intramuscular administration: an alternative cost effective approach for passive immunization against rabies","volume":"12","author":"Bharti","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.02.083_b0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.trstmh.2006.04.009","article-title":"Sex- and age-related differences in rabies immunoglobulin hypersensitivity","volume":"101","author":"Suwansrinon","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.02.083_b0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1708-8305.2011.00540.x","article-title":"The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule\u2013a case series of 420 travelers","volume":"18","author":"Mills","year":"2011","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2019.02.083_b0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4161\/21645515.2014.994460","article-title":"Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2\u20131-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study","volume":"11","author":"Li","year":"2015","journal-title":"Hum Vaccin Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T02:29:23Z","timestamp":1606789763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19303354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":28,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0264410X19303354"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}